These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 17195698

  • 1. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 2. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR, Pressler T, Hoiby N, Johansen HK.
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [Abstract] [Full Text] [Related]

  • 3. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 4. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?
    Tramper-Stranders GA, van der Ent CK, Gerritsen SA, Fleer A, Kimpen JL, Wolfs TF.
    J Antimicrob Chemother; 2007 Sep; 60(3):665-8. PubMed ID: 17604321
    [Abstract] [Full Text] [Related]

  • 5. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
    Pirzada OM, McGaw J, Taylor CJ, Everard ML.
    J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
    [Abstract] [Full Text] [Related]

  • 6. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR, Pressler T, Koch C, Høiby N.
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [Abstract] [Full Text] [Related]

  • 7. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK, Pawaiya R, Lodha R, Kapil A, Kabra M, Vani AS, Agarwal G, Shastri SS.
    J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
    [Abstract] [Full Text] [Related]

  • 8. Azithromycin for improving pulmonary function in cystic fibrosis.
    Carr RR, Nahata MC.
    Ann Pharmacother; 2004 Sep; 38(9):1520-4. PubMed ID: 15213312
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A, McGaw J, Dalton A, Beal G, Everard M, Taylor CJ.
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of azithromycin in patients with cystic fibrosis.
    Samson C, Tamalet A, Thien HV, Taytard J, Perisson C, Nathan N, Clement A, Boelle PY, Corvol H.
    Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
    [Abstract] [Full Text] [Related]

  • 11. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [Abstract] [Full Text] [Related]

  • 12. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A, Denis O, Deplano A, Casimir G, Claeys G, DeBaets F, DeBoeck K, Douat N, Franckx H, Gigi J, Ieven M, Knoop C, Lebeque P, Lebrun F, Malfroot A, Paucquay F, Pierard D, Van Eldere J, Struelens MJ.
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [Abstract] [Full Text] [Related]

  • 13. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, Waernessyckle S, Descamps P, Sermet-Gaudelus I, Lenoir G, Berche P, Taddei F.
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [Abstract] [Full Text] [Related]

  • 14. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
    Anzaudo MM, Busquets NP, Ronchi S, Mayoral C.
    Rev Argent Microbiol; 2005 Aug; 37(3):129-34. PubMed ID: 16323660
    [Abstract] [Full Text] [Related]

  • 15. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [Abstract] [Full Text] [Related]

  • 16. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS, Egan M, Kazmierczak BI.
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [Abstract] [Full Text] [Related]

  • 19. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains.
    Prunier AL, Malbruny B, Laurans M, Brouard J, Duhamel JF, Leclercq R.
    J Infect Dis; 2003 Jun 01; 187(11):1709-16. PubMed ID: 12751028
    [Abstract] [Full Text] [Related]

  • 20. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 01; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.